ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/31 | 2,154 | 2,224 | 2,150 | 2,186 | +8 | +0.4% | 557,800 |
2022/03/30 | 2,190 | 2,205 | 2,163 | 2,178 | +63 | +3% | 652,100 |
2022/03/29 | 2,098 | 2,126 | 2,046 | 2,115 | +59 | +2.9% | 549,200 |
2022/03/28 | 2,080 | 2,080 | 2,017 | 2,056 | -74 | -3.5% | 617,900 |
2022/03/25 | 2,105 | 2,147 | 2,095 | 2,130 | +75 | +3.6% | 797,800 |
2022/03/24 | 2,010 | 2,060 | 1,981 | 2,055 | +16 | +0.8% | 591,000 |
2022/03/23 | 2,000 | 2,049 | 1,986 | 2,039 | +68 | +3.5% | 858,000 |
2022/03/22 | 2,025 | 2,057 | 1,963 | 1,971 | -64 | -3.1% | 1,092,800 |
2022/03/18 | 1,985 | 2,045 | 1,973 | 2,035 | +71 | +3.6% | 1,265,200 |
2022/03/17 | 1,955 | 2,009 | 1,928 | 1,964 | +89 | +4.7% | 1,098,100 |
2022/03/16 | 1,862 | 1,897 | 1,834 | 1,875 | +53 | +2.9% | 852,200 |
2022/03/15 | 1,729 | 1,857 | 1,720 | 1,822 | +92 | +5.3% | 1,011,500 |
2022/03/14 | 1,720 | 1,776 | 1,715 | 1,730 | +2 | +0.1% | 841,400 |
2022/03/11 | 1,798 | 1,829 | 1,718 | 1,728 | -100 | -5.5% | 1,188,800 |
2022/03/10 | 1,846 | 1,878 | 1,803 | 1,828 | +84 | +4.8% | 849,200 |
2022/03/09 | 1,805 | 1,818 | 1,727 | 1,744 | -61 | -3.4% | 897,600 |
2022/03/08 | 1,800 | 1,884 | 1,794 | 1,805 | -33 | -1.8% | 850,000 |
2022/03/07 | 1,863 | 1,890 | 1,824 | 1,838 | -77 | -4% | 890,100 |
2022/03/04 | 1,997 | 2,021 | 1,902 | 1,915 | -123 | -6% | 690,500 |
2022/03/03 | 2,082 | 2,098 | 2,031 | 2,038 | -50 | -2.4% | 686,800 |
2022/03/02 | 2,128 | 2,128 | 2,056 | 2,088 | -63 | -2.9% | 706,300 |
2022/03/01 | 2,044 | 2,179 | 2,020 | 2,151 | +117 | +5.8% | 982,600 |
2022/02/28 | 1,937 | 2,049 | 1,931 | 2,034 | +86 | +4.4% | 947,900 |
2022/02/25 | 1,890 | 1,953 | 1,861 | 1,948 | +110 | +6% | 1,330,700 |
2022/02/24 | 1,953 | 1,959 | 1,826 | 1,838 | -125 | -6.4% | 1,221,600 |
2022/02/22 | 2,002 | 2,032 | 1,951 | 1,963 | -80 | -3.9% | 735,200 |
2022/02/21 | 2,009 | 2,048 | 1,970 | 2,043 | -22 | -1.1% | 630,000 |
2022/02/18 | 2,005 | 2,071 | 1,986 | 2,065 | +2 | +0.1% | 746,100 |
2022/02/17 | 2,138 | 2,138 | 2,042 | 2,063 | -81 | -3.8% | 734,800 |
2022/02/16 | 2,163 | 2,195 | 2,138 | 2,144 | +16 | +0.8% | 676,300 |
2022/02/15 | 2,068 | 2,218 | 2,052 | 2,128 | +53 | +2.6% | 1,317,700 |
2022/02/14 | 1,995 | 2,103 | 1,961 | 2,075 | +19 | +0.9% | 1,555,900 |
2022/02/10 | 2,017 | 2,130 | 2,017 | 2,056 | +106 | +5.4% | 2,041,600 |
2022/02/09 | 2,027 | 2,031 | 1,915 | 1,950 | -71 | -3.5% | 1,399,200 |
2022/02/08 | 2,020 | 2,101 | 2,013 | 2,021 | +1 | ±0% | 657,500 |
2022/02/07 | 2,123 | 2,130 | 2,012 | 2,020 | -53 | -2.6% | 645,400 |
2022/02/04 | 2,031 | 2,077 | 2,008 | 2,073 | -8 | -0.4% | 769,300 |
2022/02/03 | 2,120 | 2,135 | 2,070 | 2,081 | -108 | -4.9% | 1,151,900 |
2022/02/02 | 2,056 | 2,191 | 2,053 | 2,189 | +141 | +6.9% | 1,033,500 |
2022/02/01 | 2,083 | 2,107 | 2,030 | 2,048 | +4 | +0.2% | 817,100 |
2022/01/31 | 1,947 | 2,068 | 1,925 | 2,044 | +135 | +7.1% | 1,103,300 |
2022/01/28 | 1,952 | 1,990 | 1,876 | 1,909 | -33 | -1.7% | 1,406,100 |
2022/01/27 | 2,062 | 2,071 | 1,907 | 1,942 | -132 | -6.4% | 1,617,400 |
2022/01/26 | 2,060 | 2,124 | 2,037 | 2,074 | -10 | -0.5% | 1,015,400 |
2022/01/25 | 2,196 | 2,226 | 2,083 | 2,084 | -129 | -5.8% | 1,210,700 |
2022/01/24 | 2,178 | 2,214 | 2,126 | 2,213 | -15 | -0.7% | 855,100 |
2022/01/21 | 2,230 | 2,243 | 2,155 | 2,228 | -43 | -1.9% | 1,089,300 |
2022/01/20 | 2,279 | 2,326 | 2,237 | 2,271 | -22 | -1% | 757,400 |
2022/01/19 | 2,301 | 2,326 | 2,289 | 2,293 | -48 | -2.1% | 1,073,000 |
2022/01/18 | 2,383 | 2,393 | 2,327 | 2,341 | -39 | -1.6% | 775,100 |
801~
850
件表示中 / 2951件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 152,200円 | +5.0% | +1.5% | 0.00% | 13.02倍 | 3.46倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 309,400円 | +8.0% | -15.3% | 4.01% | 8.68倍 | 0.84倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 179,700円 | +5.9% | +684.6% | 3.06% | 11.93倍 | 1.19倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 395,000円 | +3.6% | +6.1% | 3.04% | 13.30倍 | 0.78倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
市場注目の銘柄
チャート関連のコラム